Coherus BioSciences Stock Forward View - Simple Moving Average
| CHRS Stock | USD 2.16 0.17 7.30% |
Coherus Stock outlook is based on your current time horizon.
The value of RSI of Coherus BioSciences' stock price is slightly above 60 suggesting that the stock is rather overbought by investors at this time. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Coherus, making its price go up or down. Momentum 60
Buy Extended
Oversold | Overbought |
Using Coherus BioSciences hype-based prediction, you can estimate the value of Coherus BioSciences from the perspective of Coherus BioSciences response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Moving Average forecasted value of Coherus BioSciences on the next trading day is expected to be 2.16 with a mean absolute deviation of 0.08 and the sum of the absolute errors of 4.72. Coherus BioSciences after-hype prediction price | USD 2.16 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Coherus BioSciences to cross-verify your projections. For more information on how to buy Coherus Stock please use our How to Invest in Coherus BioSciences guide.Coherus BioSciences Additional Predictive Modules
Most predictive techniques to examine Coherus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Coherus using various technical indicators. When you analyze Coherus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Coherus BioSciences Simple Moving Average Price Forecast For the 2nd of February
Given 90 days horizon, the Simple Moving Average forecasted value of Coherus BioSciences on the next trading day is expected to be 2.16 with a mean absolute deviation of 0.08, mean absolute percentage error of 0.01, and the sum of the absolute errors of 4.72.Please note that although there have been many attempts to predict Coherus Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Coherus BioSciences' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Coherus BioSciences Stock Forecast Pattern
| Backtest Coherus BioSciences | Coherus BioSciences Price Prediction | Research Analysis |
Coherus BioSciences Forecasted Value
In the context of forecasting Coherus BioSciences' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Coherus BioSciences' downside and upside margins for the forecasting period are 0.02 and 8.72, respectively. We have considered Coherus BioSciences' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Coherus BioSciences stock data series using in forecasting. Note that when a statistical model is used to represent Coherus BioSciences stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 110.2259 |
| Bias | Arithmetic mean of the errors | -0.0152 |
| MAD | Mean absolute deviation | 0.0801 |
| MAPE | Mean absolute percentage error | 0.0512 |
| SAE | Sum of the absolute errors | 4.725 |
Predictive Modules for Coherus BioSciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Coherus BioSciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Coherus BioSciences After-Hype Price Density Analysis
As far as predicting the price of Coherus BioSciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Coherus BioSciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Coherus BioSciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Coherus BioSciences Estimiated After-Hype Price Volatility
In the context of predicting Coherus BioSciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Coherus BioSciences' historical news coverage. Coherus BioSciences' after-hype downside and upside margins for the prediction period are 0.11 and 8.72, respectively. We have considered Coherus BioSciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Coherus BioSciences is dangerous at this time. Analysis and calculation of next after-hype price of Coherus BioSciences is based on 3 months time horizon.
Coherus BioSciences Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Coherus BioSciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Coherus BioSciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Coherus BioSciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.69 | 6.56 | 0.00 | 0.02 | 0 Events / Month | 6 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
2.16 | 2.16 | 0.00 |
|
Coherus BioSciences Hype Timeline
Coherus BioSciences is currently traded for 2.16. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.02. Coherus is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at 0.69%. %. The volatility of related hype on Coherus BioSciences is about 18222.22%, with the expected price after the next announcement by competition of 2.18. About 13.0% of the company shares are held by company insiders. The book value of Coherus BioSciences was currently reported as 0.76. The company last dividend was issued on the June 26, 1995. Coherus BioSciences had 2:1 split on the December 8, 1992. Given the investment horizon of 90 days the next projected press release will be in 5 to 10 days. Check out Historical Fundamental Analysis of Coherus BioSciences to cross-verify your projections. For more information on how to buy Coherus Stock please use our How to Invest in Coherus BioSciences guide.Coherus BioSciences Related Hype Analysis
Having access to credible news sources related to Coherus BioSciences' direct competition is more important than ever and may enhance your ability to predict Coherus BioSciences' future price movements. Getting to know how Coherus BioSciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Coherus BioSciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| OABI | OmniAb Inc | 0.03 | 8 per month | 2.70 | 0.06 | 7.97 | (5.31) | 15.55 | |
| IVVD | Invivyd | (0.11) | 10 per month | 0.00 | (0.01) | 11.11 | (9.43) | 46.37 | |
| SLS | Sellas Life Sciences | 0.00 | 0 per month | 4.92 | 0.19 | 14.94 | (7.41) | 34.72 | |
| CDXS | Codexis | (0.01) | 8 per month | 0.00 | (0.22) | 5.66 | (8.20) | 22.77 | |
| AVTX | Avalo Therapeutics | 0.12 | 18 per month | 0.00 | (0.05) | 6.64 | (6.28) | 23.40 | |
| PLX | Protalix Biotherapeutics | 0.00 | 0 per month | 3.23 | (0) | 3.50 | (4.49) | 16.17 | |
| CCCC | C4 Therapeutics | (0.04) | 9 per month | 0.00 | (0.10) | 8.06 | (7.00) | 24.93 | |
| IMDX | Insight Molecular Diagnostics | 0.31 | 8 per month | 4.55 | 0.02 | 9.03 | (6.67) | 22.08 | |
| SGMO | Sangamo Therapeutics | (0.01) | 8 per month | 0.00 | (0.01) | 8.51 | (6.98) | 21.63 | |
| TARA | Protara Therapeutics | 0.07 | 31 per month | 5.00 | 0.11 | 11.78 | (8.67) | 39.96 |
Other Forecasting Options for Coherus BioSciences
For every potential investor in Coherus, whether a beginner or expert, Coherus BioSciences' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Coherus Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Coherus. Basic forecasting techniques help filter out the noise by identifying Coherus BioSciences' price trends.Coherus BioSciences Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Coherus BioSciences stock to make a market-neutral strategy. Peer analysis of Coherus BioSciences could also be used in its relative valuation, which is a method of valuing Coherus BioSciences by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Coherus BioSciences Market Strength Events
Market strength indicators help investors to evaluate how Coherus BioSciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Coherus BioSciences shares will generate the highest return on investment. By undertsting and applying Coherus BioSciences stock market strength indicators, traders can identify Coherus BioSciences entry and exit signals to maximize returns.
Coherus BioSciences Risk Indicators
The analysis of Coherus BioSciences' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Coherus BioSciences' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting coherus stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.86 | |||
| Semi Deviation | 5.27 | |||
| Standard Deviation | 6.56 | |||
| Variance | 43.06 | |||
| Downside Variance | 34.45 | |||
| Semi Variance | 27.8 | |||
| Expected Short fall | (5.40) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Coherus BioSciences
The number of cover stories for Coherus BioSciences depends on current market conditions and Coherus BioSciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Coherus BioSciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Coherus BioSciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Coherus BioSciences Short Properties
Coherus BioSciences' future price predictability will typically decrease when Coherus BioSciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Coherus BioSciences often depends not only on the future outlook of the potential Coherus BioSciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Coherus BioSciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 114.8 M | |
| Cash And Short Term Investments | 126 M |
Additional Tools for Coherus Stock Analysis
When running Coherus BioSciences' price analysis, check to measure Coherus BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coherus BioSciences is operating at the current time. Most of Coherus BioSciences' value examination focuses on studying past and present price action to predict the probability of Coherus BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coherus BioSciences' price. Additionally, you may evaluate how the addition of Coherus BioSciences to your portfolios can decrease your overall portfolio volatility.